ethoxyresorufin and 7-benzyloxyquinoline

ethoxyresorufin has been researched along with 7-benzyloxyquinoline in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arista, L; Ashby, CR; Blaney, FE; Bonanomi, G; Braggio, S; Capelli, AM; Checchia, A; Damiani, F; Di-Fabio, R; Fontana, S; Gentile, G; Griffante, C; Hamprecht, D; Heidbreder, C; Marchioro, C; Micheli, F; Mugnaini, M; Piner, J; Ratti, E; Tarsi, L; Tedesco, G; Terreni, S; Worby, A1
Arista, L; Bertani, B; Braggio, S; Capelli, AM; Cremonesi, S; Di-Fabio, R; Gelardi, G; Gentile, G; Heidbreder, C; Marchioro, C; Micheli, F; Pasquarello, A; Provera, S; Tarsi, L; Tedesco, G; Terreni, S; Worby, A1

Other Studies

2 other study(ies) available for ethoxyresorufin and 7-benzyloxyquinoline

ArticleYear
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.
    Journal of medicinal chemistry, 2010, Jan-14, Volume: 53, Issue:1

    Topics: Animals; Cell Membrane; Computer Simulation; Drug Design; Guinea Pigs; Hexanes; Humans; Male; Models, Animal; Models, Chemical; Molecular Structure; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship

2010
Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists.
    Journal of medicinal chemistry, 2010, Oct-14, Volume: 53, Issue:19

    Topics: Animals; Azabicyclo Compounds; Catalytic Domain; CHO Cells; Cricetinae; Cricetulus; Humans; In Vitro Techniques; Microsomes, Liver; Models, Molecular; Radioligand Assay; Rats; Receptors, Dopamine D3; Structure-Activity Relationship; Triazoles

2010